Orthonika awarded £1.34 million Innovate UK grant to accelerate development of its total meniscus re
Summary
It is intended to fill the gap between minimally invasive meniscus repair and total knee replacement.There is currently no widely available treatment solution that allows patients to return to a pain free active lifestyle following meniscectomy, said Maria Kristina Bartolo, PhD, Chief Technology Officer at Orthonika. It uniquely combines world class material science, polymer processing and fibre engineering to develop a fully synthetic anatomical meniscus replacement for the knee joint, fulfilling a gap of high unmet clinical need. For the latest news follow us on Twitter (@OrthonikaMedtec) or by visiting our website www.orthonika.com.Meniscal injury significantly affects quality of life due to persistent knee pain, stiffness and swelling. There are currently no approved total meniscus replacement options for patients who have loss of meniscal function.Innovate UK drives productivity and economic growth by supporting businesses to develop and realise the potential of new ideas. Editorial Commentary: Knee Meniscal Allograft Transplantation Results in Significantly Improved Outcomes in the Majority Patients, but There Is Wide Variability in the Rate at Which Athletes Return to Sports.